Skip to main content
Daniel Morgensztern

Oncology

Daniel Morgensztern, MD

Professor of Medicine, Division of Oncology; Director of Thoracic Oncology, Washington University School of Medicine

Saint Louis, MO

Daniel Morgensztern, MD is a Professor of Medicine and Director of Thoracic Oncology at Washington University School of Medicine in Saint Louis, specializing in the treatment of thoracic malignancies, particularly lung cancer and esophageal cancer. His clinical practice focuses on comprehensive cancer care including systemic therapy for non-small cell lung cancer, small cell lung cancer, and esophageal malignancies. Dr. Morgensztern's research interests encompass genomics, immunotherapy, epidemi

...

30+

Years in Practice

Credentials

Board Certifications

  • Internal Medicine (American Board of Internal Medicine, 2001, renewed 2011)
  • Medical Oncology (American Board of Internal Medicine, 2004, renewed 2014)

Education & Training

  • Fundacao Tecnico-Educacional Souza Marques, Brazil — M.D., 1995
  • State University of Rio de Janeiro, Brazil — Residency, Internal Medicine and Hematology, 1998
  • University of Miami Hospital, Miami, FL — Residency, Internal Medicine, 1998-2001
  • University of Miami, Miami, FL — Fellowship, Hematology-Oncology, 2004

Peer Recognition

  • Castle ConnollyTop Doctor

    2022-2026 (5 years)

Clinical Focus

Subspecialties

Thoracic OncologyMedical Oncology

Conditions & Treatments

Lung CancerImmunotherapy

Practice Details

Hospital Affiliations

  • Siteman Cancer Center at Barnes-Jewish Hospital
  • Barnes-Jewish Hospital
  • Gary C. Werths Building at Siteman Cancer Center (4500 Forest Park Avenue, St. Louis, MO 63108)
  • Washington University Physicians Center for Advanced Medicine (4921 Parkview Place, Suite 7B, St. Louis, MO 63110)

Languages

English, Spanish, Portuguese

Experience

30+ years in practice